High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes

Hepatology

Volumn 29, Issue 1, 1999, Pages 250-256

  Prieto, Martín ^a   Berenguer, Marina ^a   Rayón, José Miguel ^a   Córdoba, Juan ^a   Argúello, Lidia ^b   Carrasco, Domingo ^a   García Herola, Antonio ^a   Olaso, Vicente ^a   De Juan, Manuel ^a   Gobernado, Miguel ^a   Mir, José ^a   Berenguer, Joaquín ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ARTICLE; GENOTYPE; GRAFT REJECTION; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN CELL; INCIDENCE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECIPIENT; VIRUS INFECTION;

ADULT; ALANINE TRANSAMINASE; FEMALE; GENOTYPE; GRAFT REJECTION; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RNA, VIRAL; SURVIVAL ANALYSIS;

EID: 0032899215     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290122     Document Type: Article

References (26)

1. Prieto M, Berenguer M, Rimola A, Loinaz C, Barrios C, Clémente G, Figueras J, et al. Liver transplantation in hepatitis C. A Spanish multicentre experience. Eur J Gastroenterol Hepatol 1998;10:771-776.
2. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-322.
3. Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Urdea M, et al. The course of hepatitis C virus infection after liver transplantation. HEPATOLOGY 1994;20:1137-1143.
4. Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. HEPATOLOGY 1994;20:24S-27S.
5. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334:815-820.
6. Boker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, Oldhaver K, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. HEPATOLOGY 1997;25:203-210.
7. Schluger LK, Sheiner PA, Thung SN, Lau JYN, Min A, Wolf DC, Fiel I, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. HEPATOLOGY 1996;23:971-976.
8. Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, Kolesnikov V, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. HEPATOLOGY 1995;21:30-34.
9. Manez R, Mateo R, Tabasco J, Kusne S, Starzl TE, Duquesnoy RJ. The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 1995;59:640-642.
10. Doughty AL, Spencer JD, Cossart YE, McCaughan GW. Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. Liver Transpl Surg 1998;4:15-21.
11. Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynes M, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995;108:1088-1096.
12. Gordon FD, Poterucha JJ, Germer J, Zein NN, Baits KP, Gross JBJ, Wiesner R, et al. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation 1997;63:1419-1423.
13. Prieto M, Olaso V, Verdú C, Córdoba J, Gisbert C, Rayón M, Carrasco D, et al. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction. HEPATOLOGY 1995;22:413-417.
14. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993;74:1093-1102.
15. Chomcynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
16. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. HEPATOLOGY 1981;1:431-435.
17. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. HEPATOLOGY 1994;19:1513-1520.
18. Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol 1987;11:1-10.
19. Olaso V, Córdoba J, Berenguer M, Prieto M, Lainez B, Argüello L, Valverde J, et al. Treatment of chronic hepatitis C with interferon-alpha. Clinical, histological, and virological implications. Rev Esp Enferm Dig 1997;89:531-550.
20. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P, Roberts JP, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. HEPATOLOGY 1996;24:1041-1046.
21. Vargas HE, Laskus T, Wang LF, Radkowski M, Poutous A, Lee R, Demetris JA, et al. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg 1998;4:22-27.
22. Freeman RB, Tran S, Lee YM, Rohrer RJ, Kaplan MM. Serum hepatitis C RNA titers after liver transplantation are nol correlated with immunosuppression or hepatitis. Transplantation 1996;61:542-546.
23. Gane EJ, Naoumov NV, Qian KP, Mondelli MU, Maertens G, Portmann BC, Lau JYN, el al. A longiludinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996;110:167-177.
24. Féray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, Reynes M, el al. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. HEPATOLOGY 1995;22:1084-1089.
25. Cattral MS, Krajden M, Wanless IR, Rezig M, Cameron R, Greig PD, Chung SW, et al. A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation 1996;61:1483-1488.
26. Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J, Pouyet M, et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. HEPATOLOGY 1997;26:500-504.